These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26394031)

  • 1. Extended-Spectrum Beta-Lactamase-Producing Bacteria in a Urology Ward: Epidemiology, Risk Factors and Antimicrobial Susceptibility Patterns.
    Medina-Polo J; Arrébola-Pajares A; Pérez-Cadavid S; Benítez-Sala R; Sopeña-Sutil R; Lara-Isla A; Alsonso-Isa M; Gil-Moradillo J; Justo-Quintas J; Miranda-Utrera N; Aguilar-Gisbert L; Passas-Martínez JB; Tejido-Sánchez Á
    Urol Int; 2015; 95(3):288-92. PubMed ID: 26394031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and risk factors of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in a medical center in Taiwan: a prospective cohort study.
    Kung CH; Ku WW; Lee CH; Fung CP; Kuo SC; Chen TL; Lee YT
    J Microbiol Immunol Infect; 2015 Apr; 48(2):168-74. PubMed ID: 24064292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
    Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
    Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria.
    Briongos-Figuero LS; Gómez-Traveso T; Bachiller-Luque P; Domínguez-Gil González M; Gómez-Nieto A; Palacios-Martín T; González-Sagrado M; Dueñas-Laita A; Pérez-Castrillón JL
    Int J Clin Pract; 2012 Sep; 66(9):891-6. PubMed ID: 22897466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Occurrence of alert pathogens in hospital environment. Part I. ESBL-producing enterobacteriaceae strains].
    Paluchowska P; Skałkowska M; Spelak A; Budak A
    Med Dosw Mikrobiol; 2012; 64(1):35-43. PubMed ID: 22808728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bahrain.
    Bindayna KM; Senok AC; Jamsheer AE
    J Infect Public Health; 2009; 2(3):129-35. PubMed ID: 20701872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-spectrum beta-lactamase-producing organisms.
    Falagas ME; Karageorgopoulos DE
    J Hosp Infect; 2009 Dec; 73(4):345-54. PubMed ID: 19596491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study analyzing risk factors and characteristics of healthcare-associated infections in a Urology ward.
    Medina-Polo J; Sopeña-Sutil R; Benítez-Sala R; Lara-Isla A; Alonso-Isa M; Gil-Moradillo J; Justo-Quintas J; García-Rojo E; González-Padilla DA; Passas-Martínez JB; Tejido-Sánchez Á
    Investig Clin Urol; 2017 Jan; 58(1):61-69. PubMed ID: 28097270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of bla(CTX-M) beta-lactamase genes in extended-spectrum beta-lactamase producing gram-negative bacteria].
    Bayraktar B; Toksoy B; Bulut E
    Mikrobiyol Bul; 2010 Apr; 44(2):187-96. PubMed ID: 20549952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
    Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004).
    Goossens H; Grabein B
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):257-64. PubMed ID: 16360549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.
    Nakai H; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Yamagishi Y; Mikamo H
    J Infect Chemother; 2016 May; 22(5):319-26. PubMed ID: 26968486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nosocomial outbreak due to extended-spectrum-beta-lactamase- producing Enterobacter cloacae in a cardiothoracic intensive care unit.
    Manzur A; Tubau F; Pujol M; Calatayud L; Dominguez MA; Peña C; Sora M; Gudiol F; Ariza J
    J Clin Microbiol; 2007 Aug; 45(8):2365-9. PubMed ID: 17581932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia.
    Martínez JA; Aguilar J; Almela M; Marco F; Soriano A; López F; Balasso V; Pozo L; Mensa J
    J Antimicrob Chemother; 2006 Nov; 58(5):1082-5. PubMed ID: 16950822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates.
    Al-Zarouni M; Senok A; Rashid F; Al-Jesmi SM; Panigrahi D
    Med Princ Pract; 2008; 17(1):32-6. PubMed ID: 18059098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).
    Hirakata Y; Matsuda J; Miyazaki Y; Kamihira S; Kawakami S; Miyazawa Y; Ono Y; Nakazaki N; Hirata Y; Inoue M; Turnidge JD; Bell JM; Jones RN; Kohno S;
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):323-9. PubMed ID: 16165001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Countrywide spread of community- and hospital-acquired extended-spectrum beta-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon.
    Moubareck C; Daoud Z; Hakimé NI; Hamzé M; Mangeney N; Matta H; Mokhbat JE; Rohban R; Sarkis DK; Doucet-Populaire F
    J Clin Microbiol; 2005 Jul; 43(7):3309-13. PubMed ID: 16000453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
    Tumbarello M; Sanguinetti M; Montuori E; Trecarichi EM; Posteraro B; Fiori B; Citton R; D'Inzeo T; Fadda G; Cauda R; Spanu T
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1987-94. PubMed ID: 17387156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study.
    Reuland EA; Sonder GJ; Stolte I; Al Naiemi N; Koek A; Linde GB; van de Laar TJ; Vandenbroucke-Grauls CM; van Dam AP
    Clin Microbiol Infect; 2016 Aug; 22(8):731.e1-7. PubMed ID: 27223840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of community-onset urinary tract infections caused by plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae.
    Lee CH; Lee YT; Kung CH; Ku WW; Kuo SC; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2015 Jun; 48(3):269-75. PubMed ID: 24239065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.